Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
the study does not need to be conducted because the physicochemical and toxicological properties suggest no potential for a significant rate of absorption through the skin
Cross-reference
Reason / purpose for cross-reference:
data waiving: supporting information
Reference
Endpoint:
basic toxicokinetics, other
Remarks:
transformation/dissolution in artificial physiological media
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2017-08-25 - 2017-11-07
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
comparable to guideline study
Objective of study:
bioaccessibility (or bioavailability)
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Series on Testing and Assessment No. 29 (23-Jul-2001): Guidance document on transformation/dissolution of metals and metal compounds in aqueous media
Deviations:
yes
Remarks:
Bioaccessibility testing: loading of 100 mg/L; five artificial physiological media agitated at 100 rpm, at 37 °C ± 2 °C; sampling after 2 h and 24 h; determination of Cr,Fe, Ti and Zn concentrations after filtration by ICP-OES.
Principles of method if other than guideline:
The test was performed on the basis of OECD Series on Testing and Assessment No. 29 as well as according to the bioaccessibility test protocol that has been developed on the basis of relevant published methods ([1], [2], [3], [4] and [5]).

The aim of this test was to assess the dissolution of the pigment IIPC-2018-011 (Chromium, iron, titanium and zinc spinel and rutile) in the artificial physiological media GST, GMB, ALF, ASW and PBS. The test media were selected to simulate relevant human-chemical interactions (as far as practical), i.e. a substance entering the human body by ingestion or by inhalation.

Five different artificial physiological media with a single loading of test substance of 100 mg/Lwere used. The measurement of dissolved iron and magnesium concentrations after filtration were performed by ICP-OES. Samples were taken after 2 and 24 hours agitation (100 rpm) at 37 ± 2 °C. The study was performed in triplicate with two additional method blanks per medium.

[1] Hanawa T. 2004. Metal ion release from metal implants. Materials Science and Engineering C 24: 745-752.
[2] Stopford W., Turner J., Cappelini D., Brock T. 2004. Bioaccessibility testing of cobalt compounds. Journal of Environmental Monitoring 5: 675-680.
[3] Midander K., et al. 2007. In vitro studies of copper release from powder particles in synthetic biological media. Environmental Pollution 145: 51-59.
[4] European standard 1998. Test method for release of nickel from products intended to come into direct and prolonged contact with the skin (EN 1811)
[5] ASTM 2003. Standard test method for determining extractability of metals from art materials. ASTM D5517-03.
GLP compliance:
yes (incl. QA statement)
Species:
other: in vitro (simulated human body fluids)
Details on test animals or test system and environmental conditions:
Test principle in brief:
- five different artificial physiological media,
- single loading of test substance of 100 mg/L,
- samples taken after 2 and 24 hours agitation (100 rpm) at 37 ± 2 °C,
- two method blanks per artificial media were tested; measurement (by ICP-OES) of dissolved chromium, iron, titanium and zinc after filtration
- the study was performed in triplicate

The aim of this test was to assess the dissolution of IPC-2018-011 (Chromium, iron, titanium and zinc spinel and rutile) in five artificial physiological media: Artificial lysosomal fluid (ALF, pH = 4.5), Artificial sweat solution (ASW, pH = 6.5), Gamble´s solution (GMB, pH = 7.4), Artificial gastric fluid (GST, pH = 1.5), Phosphate buffered saline (PBS, pH = 7.4). The test media were selected to simulate relevant human-chemical interactions (as far as practical), i.e. a substance entering the human body by ingestion into the gastrointestinal tract and by inhalation.
Duration and frequency of treatment / exposure:
Samples were taken after 2 h and 24 h.
Dose / conc.:
100 other: mg of the test item /L artificial media
Details on study design:
Reagents
The water (resistivity >18 MΩ·cm.) used for this test was purified with a Pure Lab Ultra water purification system from ELGA LabWater, Celle, Germany.
- Nitric acid - “Supra” quality (ROTIPURAN® supplied by Roth, Karlsruhe, Germany).
- Hydrochloric acid – “instra-analyzed plus” quality (J.T. Baker, Griesheim, Germany).
- Sodiumhydroxide – pro Analysis quality (Chemsolute, Th. Geyer, Renningen, Germany)

Metal analysis
- Standards:
- Certified reference materials: As quality control standards certified aqueous reference material TM-26.4 (lot no. 1115) and TMDA-52.4 (lot no. 0915) obtained from Environment Canada and a multielement standard (Roth Multielemenstandard, lot no. F38770, Karlsruhe, Germany) were analysed for total dissolved chromium, iron, titanium and zinc by ICP-OES along with the samples to determine the accuracy of the applied analytical method. Furthermore, the calibration solutions were measured along with the ICP-OES measurements as recalibration standards.

Instrumental and analytical set-up for the ICP-OES instrument:
Agilent 720, Agilent Technologies, Waldbronn, Germany
Nebulizer: Sea spray nebulizer from Agilent
Spray chamber: Glass cyclonic spray chamber from Agilent
Plasma stabilization time: at least 30 min before start of the measurements
Plasma gas flow: 15.0 L/min
Additional gas flow: 1.50 L/min
Carrier gas flow: 0.75 L/min
RF power: 1200W
Stabilization time of sample: 15 sec
Repetition time (three internal measurements per sample): 30 sec

Wavelengths: Cr: 206.158 nm, 267.716 nm and 276.653 nm
Fe: 238.204 nm, 241.052 nm and 259.837 nm
Ti: 337.280 nm, 368.520 nm and 376.132 nm
Zn: 202.548 nm, 206.200 nm and 213.857 nm

Data treatment, LOD/LOQ calculations
The applied LOD/LOQ calculations for the Agilent 720 ICP-OES are (according to DIN 32645):
LOD: 3 x standard deviation of calibration blank/slope of the calibration
LOQ: 3 x LOD
All Cr, Ti, Zn and Fe concentrations were corrected for background elemental concentrations as
determined by the means of the corresponding blank vessels.

Calibration: blank, 1 µg/L, 2 µg/l, 4 µg/L, 6 µg/L, 8 µg/L, 10 µg/L, 20 µg/L, 40 µg/L, 60 µg/L, 80 µg/L, 100 µg/L, 120 µg/L, 140 µg/L, 150 µg/L, 160 µg/L, 180 µg/L, 200 µg/L, 250 µg/L, 300 µg/L, 350 µg/L, 400 µg/L, 450 µg/L and 500 µg/L, for measurements of test vessel samples and for mass balance sample calibration was extended to 750 µg/L and 1000 µg/L.
Correlation coefficients (r): at least 0.998661
Details on dosing and sampling:
Loading:
The nominal loading in this test was 100 mg/L. However, due to weighing uncertainties the actual loadings range from 100.004 mg/L to 100.028 mg/L in the 15 test vessels.
Type:
other: Bioaccessibility
Results:
Higest dissolution at a loading of 0.1g/L in GST after 24h: Cr = 20.9µg/L, Fe = 90.2µg/L, Ti = 94.6µg/L, Zn = 112µg/L
Bioaccessibility (or Bioavailability) testing results:
Concentration of dissolved chromium in artificial physiological media (total Cr ± SD).
GST 2h: 10.3 ± 0.74 µg/L
GST 24h: 20.9 ± 0.29 µg/L
GMB 2h: 2.98 ± 0.03 µg/L
GMB 24h: 3.43 ± 0.13 µg/L
ALF 2h: 8.52 ± 0.51 µg/L
ALF 24h: 16.4 ± 0.10 µg/L
ASW 2h: 4.02 ± 0.09 µg/L
ASW 24h: 6.10 ± 0.17 µg/L
PBS 2h: 3.21 ± 0.18 µg/L
PBS 24h: 4.32 ± 0.18 µg/L

Concentration of dissolved iron in artificial physiological media (total Fe ± SD).
GST 2h: 25.2 ± 3.60 µg/L
GST 24h: 90.2 ± 1.71 µg/L
GMB 2h: 0.660 µg/L
GMB 24h: < LOD
ALF 2h: 20.0 ± 0.82 µg/L
ALF 24h: 47.9 ± 0.87 µg/L
ASW 2h: < LOD
ASW 24h: 1.46 ± 1.16 µg/L
PBS 2h: 2.00 ± 2.25 µg/L
PBS 24h: < LOD

Concentration of dissolved titanium in artificial physiological media (total Ti ± SD).
GST 2h: 25.7 ± 3.72 µg/L
GST 24h: 94.6 ± 1.76 µg/L
GMB 2h: < LOD/LOQ
GMB 24h: 0.830 ± 0.236 µg/L
ALF 2h: 18.0 ± 0.77 µg/L
ALF 24h: 46.1 ± 0.13 µg/L
ASW 2h: 1.30 ± 0.43 µg/L
ASW 24h: 19.7 ± 0.51 µg/L
PBS 2h: < LOD
PBS 24h: 1.71 ± 0.11 µg/L

Concentration of dissolved zinc in artificial physiological media (total Zn ± SD).
GST 2h: 86.9 µg/L
GST 24h: 112 µg/L
GMB 2h: 0.688 µg/L
GMB 24h: ALF 2h: 78.2 µg/L
ALF 24h: 101 µg/L
ASW 2h: 17.0 µg/L
ASW 24h: 63.0 µg/L
PBS 2h: 4.24 ± 2.04 µg/L
PBS 24h: 38.2 ± 0.84 µg/L

Method validation summary (ICP-OES)

Limits of detection (LODs), limits of quantification (LOQs) and correlation coefficients (r) are given for each medium and metal measured:

 

ASW medium

date

Chosen wavelength [nm]

LOD
(µg/L)

LOQ
(µg/L)

correlation coefficient

Sum of quality assurance samples

Recovery of quality assurance samples [%]

September 20, 2017; measurement of ASW test samples (2h and 24h) and method blanks

Cr: 267.716

Fe: 259.837

Ti: 368.520

Zn: 213.857

Cr: 0.578

Fe: 1.13

Ti: 0.068

Zn: 0.135

Cr: 1.73

Fe: 3.38

Ti: 0.204

Zn: 0.405

Cr: 0.999961

Fe: 0.999979

Ti: 0.999957

Zn: 0.999538

Cr: 37

Fe: 37

Ti: 37

Zn: 37

Cr: 100

Fe: 100

Ti: 100

Zn: 97.3

 

PBS medium

date

Chosen wavelength [nm]

LOD
(µg/L)

LOQ
(µg/L)

correlation coefficient

Sum of quality assurance samples

Recovery of quality assurance samples [%]

October 05, 2017; measurement of PBS test samples (2h and 24h) and method blanks

Cr: 206.158

Fe: 238.204

Ti: 376.132

Zn: 213.857

Cr: 0.989

Fe: 0.350

Ti: 0.201

Zn: 0.259

Cr: 2.97

Fe: 1.05

Ti: 0.604

Zn: 0.778

Cr: 0.999655

Fe: 0.999932

Ti: 0.999646

Zn: 0.998661

Cr: 40

Fe: 40

Ti: 40

Zn: 40

Cr: 100

Fe: 100

Ti: 85

Zn: 90.0

 

GMB medium

date

Chosen wavelength [nm]

LOD
(µg/L)

LOQ
(µg/L)

correlation coefficient

Sum of quality assurance samples

Recovery of quality assurance samples [%]

October 06, 2017; measurement of GMB test samples (2h and 24h) and method blanks

Cr: 267.716

Fe: 238.204

Ti: 337.280

Zn: 202.548

Cr: 0.713

Fe: 0.221

Ti: 0.290

Zn: 0.095

Cr: 2.14

Fe: 0.664

Ti: 0.871

Zn: 0.286

Cr: 0.999970

Fe: 0.999983

Ti: 0.999892

Zn: 0.999900

Cr: 40

Fe: 40

Ti: 40

Zn: 40

Cr: 100

Fe: 100

Ti: 100

Zn: 85.0

 

GST medium

date

Chosen wavelength [nm]

LOD
(µg/L)

LOQ
(µg/L)

correlation coefficient

Sum of quality assurance samples

Recovery of quality assurance samples [%]

October 11, 2017; measurement of GST test samples (2h and 24h) and method blanks

Cr: 267.716

Fe: 238.204

Ti: 337.280

Zn: 202.548

Cr: 0.359

Fe: 0.411

Ti: 0.944

Zn: 0.318

Cr: 1.08

Fe: 1.23

Ti: 2.83

Zn: 0.955

Cr: 0.999870

Fe: 0.999943

Ti: 0.999954

Zn: 0.999862

Cr: 40

Fe: 40

Ti: 40

Zn: 40

Cr: 100

Fe: 100

Ti: 97.5

Zn: 97.5

 

ALF medium

date

Chosen wavelength [nm]

LOD
(µg/L)

LOQ
(µg/L)

correlation coefficient

Sum of quality assurance samples

Recovery of quality assurance samples [%]

October 11, 2017; measurement of ALF test samples (2h and 24h) and method blanks

Cr: 267.716

Fe: 259.837

Ti: 376.132

Zn: 202.548

Cr: 0.293

Fe: 1.22

Ti: 0.463

Zn: 0.278

Cr: 0.880

Fe: 3.66

Ti: 1.39

Zn: 0.834

Cr: 0.999981

Fe: 0.999958

Ti: 0.999953

Zn: 0.999923

Cr: 40

Fe: 40

Ti: 40

Zn: 40

Cr: 100

Fe: 85.0

Ti: 100

Zn:97.5

 

Solution pH values

The target pH in all media before addition of test substance was in the nominal range.

During the study, the pH of GST, ALF and PBS media remained stable in the method blank vessels and the test vessels. Therefore, a possible effect of the test substance can be excluded.

In GMB medium, the pH in all vessels (including method blanks) increased during the time of the test from 7.44 – 7.47 to 8.68, 8.75 and 8.80 (test vessels) and 7.46 and 7.47 to 8.67 and 8.69 (method blank vessels). Therefore, an effect of the test substance can be excluded. In fact, the pH of the GMB media does not seem to be stable under the conditions of the test.

In ASW medium, the pH in all vessels (including method blanks) decreased during the time of the test from 6.53 – 6.56 to 5.99 and 6.00 (test vessels) and 6.55 to 5.89 and 5.96 (method blank vessels). Therefore, an effect of the test substance can be excluded.

Temperature control

The test was performed in an incubated laboratory shaker (Shaking incubation cabinet, Minitron, INFORS AG, Bottmingen, Switzerland) at 100 rpm. The temperature was adjusted to 37.5 °C in a thermostatically controlled shaking cabinet to reach a temperature of 37 °C ± 2 °C in the media. The temperature remained stable during the test in all media.

Fortification

Mean recovery of fortified samples: 94.0 - 116 % (Cr fortification), 73.2 - 105 % (Fe fortification), 94.7 – 102% (Ti fortification) and 97.4 – 126% (Zn fortification).

Conclusions:
On the basis of OECD Series on Testing and Assessment No. 29 as well as according to a bioaccessibility test protocol, which has been developed on the basis of relevant published methods, the dissolution of the pigment IPC-2018-011 (chromium, iron, titanium and zinc spinel and rutile) in the artificial physiological media (GST, GMB, ALF, ASW and PBS) with a single loading of 100 mg/L, agitation (100 rpm) at 37 °C ± 2 °C and sampling after 2 and 24 h, was determined. The measurement of dissolved chromium, iron, titanium and zinc concentrations after filtration were performed by ICP-OES. The study was performed in triplicate with two additional method blanks per medium.

Concentration of dissolved chromium in artificial physiological media (total Cr ± SD).
GST 2h: 10.3 ± 0.74 µg/L
GST 24h: 20.9 ± 0.29 µg/L
GMB 2h: 2.98 ± 0.03 µg/L
GMB 24h: 3.43 ± 0.13 µg/L
ALF 2h: 8.52 ± 0.51 µg/L
ALF 24h: 16.4 ± 0.10 µg/L
ASW 2h: 4.02 ± 0.09 µg/L
ASW 24h: 6.10 ± 0.17 µg/L
PBS 2h: 3.21 ± 0.18 µg/L
PBS 24h: 4.32 ± 0.18 µg/L

Concentration of dissolved iron in artificial physiological media (total Fe ± SD).
GST 2h: 25.2 ± 3.60 µg/L
GST 24h: 90.2 ± 1.71 µg/L
GMB 2h: 0.660 µg/L
GMB 24h: < LOD
ALF 2h: 20.0 ± 0.82 µg/L
ALF 24h: 47.9 ± 0.87 µg/L
ASW 2h: < LOD
ASW 24h: 1.46 ± 1.16 µg/L
PBS 2h: 2.00 ± 2.25 µg/L
PBS 24h: < LOD

Concentration of dissolved titanium in artificial physiological media (total Ti ± SD).
GST 2h: 25.7 ± 3.72 µg/L
GST 24h: 94.6 ± 1.76 µg/L
GMB 2h: < LOD/LOQ
GMB 24h: 0.830 ± 0.236 µg/L
ALF 2h: 18.0 ± 0.77 µg/L
ALF 24h: 46.1 ± 0.13 µg/L
ASW 2h: 1.30 ± 0.43 µg/L
ASW 24h: 19.7 ± 0.51 µg/L
PBS 2h: < LOD
PBS 24h: 1.71 ± 0.11 µg/L

Concentration of dissolved zinc in artificial physiological media (total Zn ± SD).
GST 2h: 86.9 µg/L
GST 24h: 112 µg/L
GMB 2h: 0.688 µg/L
GMB 24h: ALF 2h: 78.2 µg/L
ALF 24h: 101 µg/L
ASW 2h: 17.0 µg/L
ASW 24h: 63.0 µg/L
PBS 2h: 4.24 ± 2.04 µg/L
PBS 24h: 38.2 ± 0.84 µg/L

Data source

Materials and methods

Results and discussion

Applicant's summary and conclusion